الصفحة الرئيسية>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Methyltransferase>>EPZ020411 hydrochloride

EPZ020411 hydrochloride

رقم الكتالوجGC36000

هيدروكلوريد EPZ020411 هو مثبط انتقائي لـ PRMT6 مع IC50 من 10 نانومتر ، ولديه> 10 أضعاف انتقائية لـ PRMT6 على PRMT1 و PRMT8يمكن استخدام هيدروكلوريد EPZ020411 في أبحاث السرطان

Products are for research use only. Not for human use. We do not sell to patients.

EPZ020411 hydrochloride التركيب الكيميائي

Cas No.: 2070015-25-5

الحجم السعر المخزون الكميّة
10mM (in 1mL Water)
198٫00
متوفر
5mg
180٫00
متوفر
10mg
315٫00
متوفر
50mg
585٫00
متوفر
100mg
1035٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

EPZ020411 hydrochloride is a potent and selective inhibitor of PRMT6 with IC50 of 10 nM, has >10 fold selectivity for PRMT6 over PRMT1 and PRMT8.IC50 value: 10 nMTarget: PRMT6in vitro: EPZ020411 inhibits methylation of PRMT6 substrates in cells. EPZ020411 does-dependently inhibits H3R2 methylation in PRMT6-overexpressing cells.in vivo: EPZ020411 shows good bioavailability following subcutaneous (SC) dosing in rats making it a suitable tool for in vivo studies.

[1]. Mitchell LH, et al. Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 ToolCompound. ACS Med Chem Lett. 2015 Apr 6;6(6):655-659.

مراجعات

Review for EPZ020411 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for EPZ020411 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.